Logo Lanfrica

Genetic factors in acenocoumarol treatment in Tunisian patients: Personalized medicine

Créateur:
M. K. S. S.
Éditeur:
Elsevier BV
Hôte:

Licenses

https://www.elsevier.com/tdm/userlicense/1.0/https://www.elsevier.com/legal/tdmrep-licensehttp://www.elsevier.com/open-access/userlicense/1.0/

Similaires

Abstract PO-131: Therapeutic molecular targets in Egyptian colorectal cancer patients: Time for ethnic personalized medicine

Abstract Background: Colorectal cancer (CRC) in Egypt is one of the most prevalent

Evaluation of Cardiovascular Risk Factors in Tunisian Coronary Patients

Machine Learning for Personalized Medicine in Sub-Saharan Africa: A review

Personalized medicine (PM) has transformed healthcare globally by customizing treatments based on in

CDH1 and CTNNA1 Genetic Screening in Tunisian Patients with Hereditary Diffuse Gastric Carcinoma

Abstract Background : Mutational screening of the CDH1 gene is a standard treatment f

Personalized Medicine and Chronic Kidney Disease in Sub-Saharan Africa: Advances and Challenges

Abstract Chronic kidney disease is increasing in prevalence sub-Saharan Africa, largely driven by

PB1921 COMPREHENSIVE ANALYSIS OF MOLECULAR RESPONSE IN TUNISIAN CML PATIENTS FOR TREATMENT DISCONTINUATION

Background: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by a bala